| Bioactivity | H2L5186303 is a potent and selective LPA2 receptor (lysophosphatidic acid 2 receptor) antagonist with an IC50 of 9 nM[1]. | ||||||||||||
| Name | H2L5186303 | ||||||||||||
| CAS | 139262-76-3 | ||||||||||||
| Formula | C26H20N2O8 | ||||||||||||
| Molar Mass | 488.45 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Fells JI, et al. Structure-based drug design identifies novel LPA3 antagonists. Bioorg Med Chem. 2009 Nov 1;17(21):7457-64. |
H2L5186303
CAS: 139262-76-3 F: C26H20N2O8 W: 488.45
H2L5186303 is a potent and selective LPA2 receptor (lysophosphatidic acid 2 receptor) antagonist with an IC50 of 9 nM.
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.